Mark Schoenebaum serves as Executive at TG THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Mark Schoenebaum has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 26, 2018 involved receiving (via award) 15,000 shares valued at $0.
Mark Schoenebaum currently holds 125,949 shares of TG THERAPEUTICS, INC. (TGTXD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Schoenebaum has been a net neutral trader of TGTXD stock. They have purchased $0 and sold $0 worth of shares.
Mark Schoenebaum's most recent insider trade was on Jun 26, 2018, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 6, 2016 | TGTX | $0 | Award | 12,459 | $N/A | Discretionary |
| Jun 4, 2015 | TGTX | $0 | Award | 4,667 | $N/A | Discretionary |
| Jun 6, 2014 | TGTX | $0 | Award | 11,538 | $N/A | Discretionary |
| Jun 5, 2013 | TGTX | $0 | Award | 8,404 | $N/A | Discretionary |
| Mar 15, 2013 | TGTX | $0 | Award | 8,881 | $N/A | Discretionary |
| May 16, 2012 | TGTXD | $0 | Award | 50,000 | $N/A | Discretionary |